What therapeutic classification does Diltiazem Hydrochloride fall under?

What therapeutic classification does Diltiazem Hydrochloride fall under?

• A. Beta-blocker
• B. Calcium channel blocker
• C. ACE inhibitor
• D. Sodium channel blocker

Answer: (B)

Diltiazem Hydrochloride is classified as a calcium channel blocker. This class of medications works by inhibiting the influx of calcium ions into cardiac and smooth muscle cells through voltage-gated calcium channels. By doing so, diltiazem leads to relaxation of vascular smooth muscle and decreases heart rate, which helps reduce blood pressure and improve blood flow. Calcium channel blockers like diltiazem are commonly used to treat conditions such as hypertension, angina (chest pain), and certain arrhythmias. The therapeutic effects result from the drug’s ability to reduce myocardial oxygen demand and increase oxygen supply to the heart. In contrast, medications in other classifications, such as beta-blockers, ACE inhibitors, and sodium channel blockers, function through different mechanisms. Beta-blockers primarily reduce heart rate and myocardial contractility, ACE inhibitors inhibit the renin-angiotensin-aldosterone system to lower blood pressure, and sodium channel blockers primarily interfere with the sodium channels to influence electrical activity in the heart. Thus, diltiazem's efficacy in managing cardiovascular conditions is distinctly attributed to its role as a calcium channel blocker.

Diltiazem Hydrochloride is classified as a calcium channel blocker. This class of medications works by inhibiting the influx of calcium ions into cardiac and smooth muscle cells through voltage-gated calcium channels. By doing so, diltiazem leads to relaxation of vascular smooth muscle and decreases heart rate, which helps reduce blood pressure and improve blood flow.

Calcium channel blockers like diltiazem are commonly used to treat conditions such as hypertension, angina (chest pain), and certain arrhythmias. The therapeutic effects result from the drug’s ability to reduce myocardial oxygen demand and increase oxygen supply to the heart.

In contrast, medications in other classifications, such as beta-blockers, ACE inhibitors, and sodium channel blockers, function through different mechanisms. Beta-blockers primarily reduce heart rate and myocardial contractility, ACE inhibitors inhibit the renin-angiotensin-aldosterone system to lower blood pressure, and sodium channel blockers primarily interfere with the sodium channels to influence electrical activity in the heart. Thus, diltiazem's efficacy in managing cardiovascular conditions is distinctly attributed to its role as a calcium channel blocker.